Chennai, India

Venkateshwarlu Jakkala

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Merck Sharp + Dohme Corp., Orchid Pharma Ltd.. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Venkateshwarlu Jakkala. Retrieved from https://idiyas.com/inventor/venkateshwarlu-jakkala

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


 

Average Co-Inventor Count = 16.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Venkateshwarlu Jakkala: Innovator in Antibiotic Development

Introduction

Venkateshwarlu Jakkala is a notable inventor based in Chennai, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of new antibiotic compounds. His work focuses on addressing the growing challenge of drug-resistant bacterial infections.

Latest Patents

Jakkala holds a patent for "Substituted carbapenems for the treatment of bacterial infections." This invention relates to carbapenem compounds that may be useful for treating bacterial infections, especially those that are drug-resistant. The patent includes details on the chemical formula of these compounds, their stereoisomers, pharmaceutically acceptable salts, and N-oxides. Additionally, it outlines the processes for preparing these compounds and their pharmaceutical compositions.

Career Highlights

Throughout his career, Venkateshwarlu Jakkala has worked with prominent companies in the pharmaceutical industry. He has been associated with Orchid Pharma Ltd. and Merck Sharp & Dohme Corporation, where he contributed to various research and development projects aimed at combating bacterial infections.

Collaborations

Jakkala has collaborated with several professionals in his field, including Gopalan Balasubramanian and Maneesh Paul-Satyaseela. These collaborations have enhanced his research efforts and contributed to the advancement of antibiotic therapies.

Conclusion

Venkateshwarlu Jakkala's innovative work in developing carbapenem compounds represents a significant step forward in the fight against bacterial infections. His contributions are vital in addressing the urgent need for effective treatments against drug-resistant bacteria.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…